Menu
Back to Journals » Cancer Management and Research » Volume 13
Review
Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,047 | Dovepress* | 3,759+ | 219 | 3,978 | |
| PubMed Central* | 288 | 98 | 386 | ||
| Totals | 4,047 | 317 | 4,364 | ||
| *Since 4 October 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar